Literature DB >> 20226249

Mumps vaccine effectiveness in highly immunized populations.

Angela Domínguez1, Núria Torner, Jesús Castilla, Joan Batalla, Pere Godoy, Marcela Guevara, Dolors Carnicer, Joan Caylà, Cristina Rius, Josep Maria Jansà.   

Abstract

The aim of the study was to investigate effectiveness of mumps MMR component in communities with high MMR coverage. Outbreak-related cases of mumps born between 1995 and 2005 notified to Navarre and Catalonia public health services during the period 2005-2007 were studied. Vaccine effectiveness (VE) and their 95%CI were calculated using the screening method. Of 47 confirmed, 85.1% immunized with at least one dose (1MMR) and 44.9% with two (2MMR). Estimated VE was 85.4% (95%CI: 67.3-93.4) for 1MMR and 88.5% (95%CI: 78.1-93.9) for 2MMR. High 2MMR coverage, improved confirmation techniques and further VE studies with all confirmed cases are needed to prevent further outbreaks. (c) 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20226249     DOI: 10.1016/j.vaccine.2010.02.107

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.

Authors:  Wei Qin; Yao Wang; Tao Yang; Xiao-Kang Xu; Xiang-Mei Meng; Chang-Jun Zhao; Shao-Yi Li; Shao-Yu Xie; Kai-Chun Li; Hong Su
Journal:  Hum Vaccin Immunother       Date:  2019-03-15       Impact factor: 3.452

Review 2.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

Review 5.  Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.

Authors:  Andrea-Ioana Beleni; Stefan Borgmann
Journal:  Int J Environ Res Public Health       Date:  2018-07-31       Impact factor: 3.390

Review 6.  Chinese expert consensus on immunoprophylaxis of common respiratory pathogens in children (2021 edition).

Authors:  Zifeng Yang; Tiejian Feng; Wenda Guan; Jianfeng He; Rongmeng Jiang; Gang Liu; Gen Lu; Quan Lu; Adong Shen; Lihong Sun; Xiaodong Sun; Yonghong Yang; Mei Zeng; Jiushun Zhou; Kunling Shen; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

7.  Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.

Authors:  Gaby Smits; Liesbeth Mollema; Susan Hahné; Hester de Melker; Irina Tcherniaeva; Sandra Waaijenborg; Rob van Binnendijk; Fiona van der Klis; Guy Berbers
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.